Market Tracker

10/31 7:05pm ET

Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.35
Data as of Oct 31
 -0.01 / -0.74%
Today’s Change
1.11
Today|||52-Week Range
2.25
-34.78%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close1.36
Today’s open1.41
Day’s range1.31 - 1.41
Volume614,739
Average volume (3 months)599,613
Market cap$204.9M
Dividend yield--
Data as of 4:03pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)-18.72%
Earnings growth (this year)+22.14%
Earnings growth (next 5 years)--
Revenue growth (last year)+1,335.94%
P/E ratioNM
Price/Sales223.01
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AMPEAmpio Pharmaceutical...-0.02-0.51%
CARACara Therapeutics In...-0.18-1.96%
ATNMActinium Pharmaceuti...+0.17+2.46%
NNVCNanoViricides Inc-0.01-0.26%
Data as of 4:03pm ET, 10/31/2014

Financials

Last reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.1M
Annual profit (last year)-$42.7M
Net profit margin-3,776.61%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Rick Gonzalez
President &
Chief Business Officer
Thomas H. Tulip
Corporate headquarters
Dublin, Ohio

Forecasts